Moderna Call Options Surge 75% in Unusual Trading

Traders snap up Moderna call options as stock price rises

Published on Feb. 13, 2026

Got story updates? Submit your updates here. ›

Moderna, Inc. (NASDAQ:MRNA) saw a significant increase in call option trading on Friday, with traders buying 146,946 call options - a 75% jump from the average daily volume. The surge in call option activity comes as Moderna's stock price rose, reaching $42.97 per share during midday trading.

Why it matters

The spike in Moderna call option trading suggests investors are betting on the biotech company's stock price continuing to rise. This could indicate growing optimism about Moderna's business prospects, potentially driven by factors like the ongoing demand for its COVID-19 vaccine or progress in its pipeline of other mRNA-based therapies.

The details

Moderna's call option volume surged to 146,946 contracts on Friday, up from an average daily volume of 83,847 contracts. This represents an approximately 75% increase in call option activity. Moderna's stock price rose $2.86, or 7.1%, to close at $42.97 per share on the day.

  • Moderna's call option trading spiked on Friday, February 13, 2026.

The players

Moderna, Inc.

A biotechnology company headquartered in Cambridge, Massachusetts that specializes in messenger RNA (mRNA) therapeutics and vaccines, including the first FDA-approved mRNA-based COVID-19 vaccine.

Got photos? Submit your photos here. ›

The takeaway

The surge in Moderna call option trading suggests investors are bullish on the company's prospects, potentially driven by continued strong demand for its COVID-19 vaccine or progress in its pipeline of other mRNA-based therapies. This activity could signal growing optimism about Moderna's long-term growth potential.